Rheumatoid arthritis drug may reduce inflammation after stroke
The pro-inflammatory cytokine interleukin-1 plays a significant role in brain injury following ischemic stroke by inducing peripheral inflammatory mediators, such as interleukin-6. However, pre-clinical studies show its effects are reduced by the interleukin-1 receptor antagonist.
Source: Clinical Pharmacist - Category: Drugs & Pharmacology Source Type: research
More News: Arthritis | Brain | Drugs & Pharmacology | Ischemic Stroke | Neurology | Rheumatoid Arthritis | Rheumatology | Stroke | Study